Senbel, Eric
Durand, Frederick
Roux, Baptiste
Badaoui, Fatima-Zohra
Fautrel, Bruno
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 9 March 2021
Accepted: 20 April 2021
First Online: 3 May 2021
Funding
: Funding and payment of the Rapid Service Fee was provided by Eli Lilly and Company, Indianapolis, IN, USA. All authors had complete access to the data used in this study and take full responsibility for the integrity of the data and accuracy of the data analysis.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work, and have given their approval this version for to be published.
: All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Baptiste Roux, Eric Senbel, Bruno Fautrel, and Frederick Durand. Bruno Fautrel, Frederick Durand, Eric Senbel, and Baptiste Roux planned and directed data interpretation. All authors contributed to manuscript drafting, provided critical revision throughout, and approved the final version for submission.
: Luke M. Healy, PhD, and Adam Clooney, PhD, (both employees of Eli Lilly and Company) provided writing and editorial support for this manuscript.
: Baptiste Roux is an employee of FAST4. FAST4 was paid by Eli Lilly and Company to conduct the current study. Frederick Durand is an employee and shareholder of Eli Lilly and Company. Fatima-Zohra Badaoui is an employee of Eli Lilly and Company. Eric Senbel has received consultancy fees from Eli Lilly and Company. Bruno Fautrel has received research grant support and consultancy fees from Eli Lilly and Company.
: This study involved the elicitation of physician preference and was conducted in accordance with French regulatory requirements. The protocol and all administrative documents, including the financial agreement, were approved by the National Medical Council (Conseil National de l’Ordre des Médecins [CNOM]). The database was declared to the National Data Protection Authority (Commission Nationale de l’Informatique et des Libertés [CNIL]). Submission to an ethics committee was not required under French law.
: All data generated or analyzed during this study are included in this published article as a supplementary information file.
: Preliminary results from this analysis were presented in poster format at the European League Against Rheumatism (EULAR) 2020 Annual Meeting.